Angstrom Bio, Inc. — Form D
Angstrom Bio, Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-04. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-06-04
- Form: D
- Accession: 0001860223-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 1
- Date of first sale: 2021-05-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-401812
Issuer
- Name: Angstrom Bio, Inc.
- CIK: 0001860223
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1108 LAVACA STREET, AUSTIN, TX, 78701-2172
- Phone: 314-229-0564
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Forrest Cox | Director | Austin, TX |
| Jonathan Feldmann | Director | Austin, TX |
| Carlos Santos | Director | Austin, TX |
| Forrest Cox | Executive Officer | Austin, TX |
| Jonathan Feldmann | Executive Officer | Austin, TX |
| Carlos Santos | Executive Officer | Austin, TX |
More